Physician profile
David Cohn
NPI 1740252261
$3,004.79
in general payments reported to CMS, 2019-2025
18 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $84.87 · 2021: $26.55 · 2022: $1,713 · 2023: $431 · 2024: $153 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533 · Consulting Fee: $150 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.76 |
| Consulting Fee | $150.00 |
| Education | $117.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,489.57 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $267.57 | 2019-2023 | Breztri, Tezspire, Symbicort |
| Jazz Pharmaceuticals INC. | $252.44 | 2019-2025 | Xywav |
| Glaxosmithkline, LLC. | $238.46 | 2019-2023 | Trelegy Ellipta, Nucala |
| Harmony Biosciences LLC | $179.14 | 2020-2023 | Wakix |
| Amgen INC. | $170.14 | 2022-2025 | Repatha |
| Genzyme Corporation | $102.95 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $74.21 | 2019-2025 | Verquvo, Belsomra |
| Regeneron Healthcare Solutions, INC. | $44.02 | 2022-2023 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.90 | 2019 | |
| Insmed, INC. | $31.18 | 2024-2025 | Brinsupri, Arikayce |
| Novartis Pharmaceuticals Corporation | $20.32 | 2023 | |
| Coloplast Corp | $19.40 | 2019 | |
| Medtronic, INC. | $17.63 | 2024 | Interstim |
| Resmed Corp | $16.96 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.45 | 2019 | |
| Axsome Therapeutics, INC. | $14.34 | 2023 | Sunosi |
| Shire North American Group INC | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.